Financial Summary (All financials)
| In millions, except per share items | Mar-31-18 | Mar-31-17 | Mar-31-16 | Mar-31-15 | Mar-31-14 | Mar-31-13 |
| Revenues | 0 | 0 | 0 | 148,189 | 132,170 | 116,266 |
| Revenue growth | | | -100.0% | 12.1% | 13.7% | |
| Cost of goods sold | 0 | 0 | 0 | 62,786 | 56,369 | 55,687 |
| Gross profit | 0 | 0 | 0 | 85,403 | 75,801 | 60,579 |
| Gross margin | | | | 57.6% | 57.4% | 52.1% |
| Selling, general and administrative | 0 | 0 | 0 | 42,585 | 38,783 | 34,272 |
| Research and development | | | | 17,449 | 12,402 | 7,674 |
| EBIT | 0 | 0 | 0 | 27,246 | 25,190 | 19,197 |
| EBIT margin | | | | 18.4% | 19.1% | 16.5% |
| Pre-tax income | 0 | 0 | 0 | 28,163 | 26,606 | 21,676 |
| Income taxes | 0 | 0 | 0 | 5,984 | 5,094 | 4,900 |
| Tax rate | | | | 21.2% | 19.1% | 22.6% |
| Net income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net margin | | | | 0.0% | 0.0% | 0.0% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Shares outstanding (diluted) | 166,185,552 | 166,997,675 | 171,072,780 | 170,933,433 | 170,695,017 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|